Glaucoma Therapeutics Market Analysis
The Glaucoma Therapeutics Market, valued at USD 7.25 million in 2023, is poised for remarkable expansion. According to recent market analysis, the market is expected to reach USD 9.62 million by 2031, demonstrating a compound annual growth rate (CAGR) of 3.6% over the forecast period from 2024 to 2031.
Glaucoma, a leading cause of irreversible blindness...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian